CD86 +1057G/A polymorphism and risk of chronic immune thrombocytopenia

References

• Gu, D., J. Ge, W. Du, et al. 2009. Raised expression of APRIL in Chinese patients with immune thrombocytopenia and its clinical implications. Autoimmunity. 42: 692–698
   PubMed Web of Science ®Google Scholar
• McKenzie, C. G., L. Guo, J. Freedman, and J. W. Semple. 2013. Cellular immune dysfunction in immune thrombocytopenia (ITP). Br. J. Haematol. 163: 10–23
   PubMed Web of Science ®Google Scholar
• Zhou, Z., Z. Chen, H. Li, et al. 2009. BAFF and BAFF-R of peripheral blood and spleen mononuclear cells in idiopathic thrombocytopenic purpura. Autoimmunity. 42: 112–119
   PubMed Web of Science ®Google Scholar
• Ogawara, H., H. Handa, K. Morita, et al. 2003. High th1/th2 ratio in patients with chronic idiopathic thrombocytopenic purpura. Eur. J. Haematol. 71: 283–288
   PubMed Web of Science ®Google Scholar
• Liu, B., H. Zhao, M. C. Poon, et al. 2007. Abnormality of CD4(+)CD25(+) regulatory t cells in idiopathic thrombocytopenic purpura. Eur. J. Haematol. 78: 139–143
   PubMed Web of Science ®Google Scholar
• Olsson, B., P. O. Andersson, M. Jernas, et al. 2003. T-cell-mediated cytotoxicity toward platelets in chronic idiopathic thrombocytopenic purpura. Nat. Med. 9: 1123–1124
   PubMed Web of Science ®Google Scholar
• Olsson, B., P. O. Andersson, S. Jacobsson, et al. 2005. Disturbed apoptosis of T-cells in patients with active idiopathic thrombocytopenic purpura. Thromb. Haemost. 93: 139–144
   PubMed Web of Science ®Google Scholar
• Jeannin, P., N. Herbault, Y. Delneste, et al. 1999. Human effector memory T cells express CD86: a functional role in naive t cell priming. J. Immunol. 162: 2044–2048
   PubMed Web of Science ®Google Scholar
• Sansom, D. M., C. N. Manzotti, and Y. Zheng. 2003. What's the difference between CD80 and CD86? Trends Immunol. 24: 314–319
   PubMed Web of Science ®Google Scholar
• Waterhouse, P., J. M. Penninger, E. Timms, et al. 1995. Lymphoproliferative disorders with early lethality in mice deficient in ctla-4. Science. 270: 985–988
   PubMed Web of Science ®Google Scholar
• Lim, T. S., J. K. Goh, A. Mortellaro, et al. 2012. CD80 and CD86 differentially regulate mechanical interactions of T-cells with antigen-presenting dendritic cells and B-cells. PLoS One. 7: e45185
   PubMed Web of Science ®Google Scholar
• Njau, M. N., and J. Jacob. 2013. The CD28/B7 pathway: a novel regulator of plasma cell function. Adv. Exp. Med. Biol. 785: 67–75
   PubMed Web of Science ®Google Scholar
• Vincenti, F. 2008. Costimulation blockade in autoimmunity and transplantation. J. Allergy Clin. Immunol. 121: 299–306; quiz 307–298
   PubMed Web of Science ®Google Scholar
• Martin-Orozco, N., and C. Dong. 2007. Inhibitory costimulation and anti-tumor immunity. Semin. Cancer Biol. 17: 288–298
   PubMed Web of Science ®Google Scholar
• Wang, C. M., G. Y. Sheng, X. Zou, et al. 2009. Levels of toll-like receptors-2,-4 on platelets in children with idiopathic thrombocytopenic purpura. Zhongguo Dang Dai Er Ke Za Zhi. 11: 797–801
   PubMedGoogle Scholar
• Ma, X. R., Y. X. Chen, W. G. Zhang, et al. 2009. Expression of co-stimulatory molecules in peripheral blood of patients with idiopathic thrombocytopenic purpura in relation with platelet antibodies. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 17: 483–486
   PubMedGoogle Scholar
• Pan, J. L., X. R. Guan, X. H. Ma, and X. He. 2007. Expression of co-stimulatory molecules and role of interleukin 18 in peripheral lymphocytes of patients with idiopathic thrombocytopenic purpura. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 15: 578–580
   PubMedGoogle Scholar
• Chu, X. X., B. H. Huang, L. M. Chen, et al. 2010. Role of dendritic cells and their toll-like receptor 4 in the pathogenesis of idiopathic thrombocytopenic purpura. Zhonghua Xue Ye Xue Za Zhi. 31:613–616
   PubMedGoogle Scholar
• Xu, G. F., L. S. Zhang, L. J. Li, et al. 2012. The immune effects of rituximab on dendritic cells derived from patients with primary immune thrombocytopenia. Zhonghua Xue Ye Xue Za Zhi. 33: 207–210
   PubMedGoogle Scholar
• Peng, J., C. Liu, D. Liu, et al. 2003. Effects of B7-blocking agent and/or CSA on induction of platelet-specific T-cell anergy in chronic autoimmune thrombocytopenic purpura. Blood. 101: 2721–2726
   PubMed Web of Science ®Google Scholar
• Jellis, C. L., S. S. Wang, P. Rennert, et al. 1995. Genomic organization of the gene coding for the costimulatory human b-lymphocyte antigen B7-2 (CD86). Immunogenetics. 42: 85–89
   PubMed Web of Science ®Google Scholar
• Delneste, Y., R. Bosotti, G. Magistrelli, et al. 2000. Detection of a polymorphism in exon 8 of the human CD86 gene. Immunogenetics. 51: 762–763
   PubMed Web of Science ®Google Scholar
• Slavik, J. M., J. E. Hutchcroft, and B. E. Bierer. 1999. CD80 and CD86 are not equivalent in their ability to induce the tyrosine phosphorylation of CD28. J. Biol. Chem. 274: 3116–3124
   PubMed Web of Science ®Google Scholar
• Emmerich, F., G. Bal, A. Barakat, et al. 2007. High-level serum B-cell activating factor and promoter polymorphisms in patients with idiopathic thrombocytopenic purpura. Br. J. Haematol. 136: 309–314
   PubMed Web of Science ®Google Scholar
• Saitoh, T., T. Kasamatsu, M. Inoue, et al. 2011. Interleukin-10 gene polymorphism reflects the severity of chronic immune thrombocytopenia in Japanese patients. Int. J. Lab. Hematol. 33: 526–532
   PubMed Web of Science ®Google Scholar
• Saitoh, T., N. Tsukamoto, H. Koiso, et al. 2011. Interleukin-17F gene polymorphism in patients with chronic immune thrombocytopenia. Eur. J. Haematol. 87: 253–258
   PubMed Web of Science ®Google Scholar
• Rodeghiero, F., R. Stasi, T. Gernsheimer, et al. 2009. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood. 113: 2386–2393
   PubMed Web of Science ®Google Scholar
• Zeller, B., J. Rajantie, I. Hedlund-Treutiger, et al. 2005. Childhood idiopathic thrombocytopenic purpura in the nordic countries: epidemiology and predictors of chronic disease. Acta Paediatr. 94: 178–184
   PubMed Web of Science ®Google Scholar
• Decker, P., I. Kotter, R. Klein, et al. 2006. Monocyte-derived dendritic cells over-express CD86 in patients with systemic lupus erythematosus. Rheumatology (Oxford). 45: 1087–1095
   PubMed Web of Science ®Google Scholar
• Nagafuchi, H., Y. Shimoyama, J. Kashiwakura, et al. 2003. Preferential expression of B7.2 (CD86), but not B7.1 (CD80), on b cells induced by CD40/CD40L interaction is essential for anti-DNA autoantibody production in patients with systemic lupus erythematosus. Clin. Exp. Rheumatol. 21: 71–77
   PubMed Web of Science ®Google Scholar
• Balsa, A., J. Dixey, D. M. Sansom, et al. 1996. Differential expression of the costimulatory molecules B7.1 (CD80) and B7.2 (CD86) in rheumatoid synovial tissue. Br. J. Rheumatol. 35: 33–37
   PubMedGoogle Scholar
• Marín, L. A., M. R. Moya-Quiles, M. Miras, et al. 2005. Evaluation of CD86 gene polymorphism at + 1057 position in liver transplant recipients. Transpl. Immunol. 15: 69–74
   PubMed Web of Science ®Google Scholar
• Krichen, H., I. Sfar, R. Bardi, et al. 2011. CD86 +1057G>A polymorphism and susceptibility to acute kidney allograft rejection. Iran J. Kidney Dis. 5: 187–193
   PubMed Web of Science ®Google Scholar
• Dalla-Costa, R., M. R. Pincerati, M. H. Beltrame, et al. 2010. Polymorphisms in the 2q33 and 3q21 chromosome regions including t-cell coreceptor and ligand genes may influence susceptibility to pemphigus foliaceus. Hum. Immunol. 71: 809–817
   PubMed Web of Science ®Google Scholar
• Wang, W., H. Song, J. Liu, et al. 2011. CD86 + 1057G/A polymorphism and susceptibility to osteosarcoma. DNA Cell Biol. 30: 925–929
   PubMed Web of Science ®Google Scholar
• Xiang, H., W. Zhao, Y. Sun, et al. 2012. CD86 gene variants and susceptibility to pancreatic cancer. J. Cancer Res. Clin. Oncol. 138: 2061–2067
   PubMed Web of Science ®Google Scholar
• Matsushita, M., N. Tsuchiya, T. Oka, et al. 2000. New polymorphisms of human CD80 and CD86: lack of association with rheumatoid arthritis and systemic lupus erythematosus. Genes Immun. 1: 428–434
   PubMed Web of Science ®Google Scholar
• Liu, C. P., J. A. Jiang, T. Wang, et al. 2013. CTLA-4 and CD86 genetic variants and haplotypes in patients with rheumatoid arthritis in southeastern china. Genet. Mol. Res. 12: 1373–1382
   PubMed Web of Science ®Google Scholar
• Corydon, T. J., A. Haagerup, T. G. Jensen, et al. 2007. A functional CD86 polymorphism associated with asthma and related allergic disorders. J. Med. Genet. 44: 509–515
   PubMed Web of Science ®Google Scholar
• Handa, T., S. Nagai, I. Ito, et al. 2005. Polymorphisms of b7 (CD80 and CD86) genes do not affect disease susceptibility to sarcoidosis. Respiration. 72: 243–248
   PubMed Web of Science ®Google Scholar